Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study
- DOI
- 10.1016/j.breast.2022.02.005
- Published
- 2022-04
- Container
- The Breast
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.breast.2022.02.005,
title = {Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study},
author = {Fábio Cardoso Borges and Filipa Alves da Costa and Adriana Ramos and Catarina Ramos and Catarina Bernardo and Cláudia Brito and Alexandra Mayer-da-Silva and Cláudia Furtado and Arlindo R. Ferreira and Diogo Martins-Branco and Ana Miranda and António Lourenço},
year = {2022},
journal = {The Breast},
doi = {10.1016/j.breast.2022.02.005},
url = {https://doi.org/10.1016/j.breast.2022.02.005}
}RIS
TY - JOUR TI - Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study AU - Fábio Cardoso Borges AU - Filipa Alves da Costa AU - Adriana Ramos AU - Catarina Ramos AU - Catarina Bernardo AU - Cláudia Brito AU - Alexandra Mayer-da-Silva AU - Cláudia Furtado AU - Arlindo R. Ferreira AU - Diogo Martins-Branco AU - Ana Miranda AU - António Lourenço PY - 2022 JO - The Breast DO - 10.1016/j.breast.2022.02.005 UR - https://doi.org/10.1016/j.breast.2022.02.005 ER -
APA
Borges, F. C., Costa, F. A. D., Ramos, A., Ramos, C., Bernardo, C., Brito, C., Mayer-da-Silva, A., Furtado, C., Ferreira, A. R., Martins-Branco, D., Miranda, A., & Lourenço, A. (2022). Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study. The Breast. https://doi.org/10.1016/j.breast.2022.02.005
Source records
- crossref · retrieved 2026-09-25T16:40:58.359Z